Research & Insights
Read and download white-papers published by Lokavant
March 8, 2022, 3:00 ET
Using our proprietary historical trial data, Lokavant conducted an analysis to investigate key predictive factors that increased or decreased risk of participant discontinuation in COVID-19 impacted clinical trials.
Mar 25, 2021, 09:00 ET
Using machine learning models and a combination of historical and within-trial data, Lokavant was able to predict key enrollment outcomes earlier in a study’s trajectory and with 95% accuracy
Feb 11th, 2020, 10:00 ET
The pandemic has driven rapid adoption of decentralized clinical trials, but measuring the effectiveness and risk of these efforts on enrollment has been difficult to date.
Lokavant partnered with THREAD to conduct the first ever impact analysis of DCTs on key performance indicators during the pandemic. Using proprietary data from over 300 ongoing COVID-impacted trials and data from THREAD, Lokavant’s analytical platform showcased the ability of decentralized approaches to mitigate COVID-related risks.